Monoclonal antibodies against ANGPTL3
US8742075B2 · kind B2 · utility
12Cited by
2References
17Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 28, 2011 |
| Grant date | Jun 3, 2014 |
| Priority date | — |
| Expiry date | Mar 28, 2031 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2317/92
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Monoclonal antibodies that specifically bind to ANGPTL3 are provided. Monoclonal antibodies that neutralize at least one activity of ANGPTL3 are provided. Methods of treating a disorder of lipid metabolism using neutralizing monoclonal antibodies are provided.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.